Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 419-428

  Khan, Ilvira M ^a   Dai Perrard, Xiao Yuan ^a   Perrard, Jerry L ^a   Mansoori, Amir ^a   Wayne Smith, C ^a   Wu, Huaizhu ^a   Ballantyne, Christie M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Inflammation; Obesity; Skeletal muscle; T cells

Indexed keywords

FATTY ACID; GAMMA INTERFERON; GLUCOSE; GLYCOPROTEIN P 15095; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRIACYLGLYCEROL; CULTURE MEDIUM; FAT INTAKE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; ADOPTIVE TRANSFER; ALPHA BETA T LYMPHOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ INTERFERON GAMMA+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL SIZE; CONTROLLED STUDY; EVALUATION STUDY; FATTY ACID BLOOD LEVEL; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MACROPHAGE; MALE; METABOLIC DISORDER; MOUSE; MYOTUBE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; T CELL DEPLETION; T LYMPHOCYTE; TH1 CELL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CELL LINE; COMPLICATION; CULTURE MEDIUM; DEFICIENCY; FAT INTAKE; GENE EXPRESSION PROFILING; HYPERTRIGLYCERIDEMIA; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTOPENIA; METABOLISM; MYOSITIS; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

3T3-L1 CELLS; ADIPOSE TISSUE; ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CULTURE MEDIA, CONDITIONED; DIETARY FATS; GENE EXPRESSION PROFILING; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INTERFERON-GAMMA; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSITIS; OBESITY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 84896267299     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.011     Document Type: Article

References (41)

1. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. JClin Invest 2003, 112:1821-1830.
2. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. JClin Invest 2007, 117:175-184.
3. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. JClin Invest 2003, 112:1796-1808.
4. Kintscher U., Hartge M., Hess K., et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28:1304-1310.
5. Rausch M.E., Weisberg S., Vardhana P., Tortoriello D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 2008, 32:451-463.
6. Wu H., Ghosh S., Perrard X.D., et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007, 115:1029-1038.
7. Nishimura S., Manabe I., Nagasaki M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920.
8. Wu H., Perrard X.D., Wang Q., et al. CD11c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler Thromb Vasc Biol 2010, 30:186-192.
9. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. JBiol Chem 1993, 268:26055-26058.
10. Salles J., Tardif N., Landrier J.F., et al. TNFalpha gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice. Nutr Biochem 2012 Dec, 23(12):1685-1693.
11. Rocha V.Z., Folco E.J., Sukhova G., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008, 103:467-476.
12. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008, 9:367-377.
13. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001, 104:517-529.
14. Hong E.G., Ko H.J., Cho Y.R., et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009, 58:2525-2535.
15. Varma V., Yao-Borengasser A., Rasouli N., et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 2009, 296:E1300-E1310.
16. Feuerer M., Herrero L., Cipolletta D., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009, 15:930-939.
17. Winer S., Chan Y., Paltser G., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, 15:921-929.
18. Wong N, Fam BC, Cempako GR, etal. Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice. Endocrinology; 152: 3690-9.
19. Strissel K.J., DeFuria J., Shaul M.E., Bennett G., Greenberg A.S., Obin M.S. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010, 18:1918-1925.
20. Fitch F.W., Gajewski T.F., Hu-Li J. Production of TH1 and TH2 cell lines and clones. Curr Protoc Immunol 2006, [chapter 3: Unit 3 13].
21. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
22. Rieusset J., Bouzakri K., Chevillotte E., Ricard N., Jacquet D., Bastard J.P., et al. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 2004, 53:2232-2241.
23. Gunn M.D., Nelken N.A., Liao X., Williams L.T. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. JImmunol 1997, 158:376-383.
24. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990, 347:669-671.
25. Fasshauer M., Paschke R., Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie 2004, 86:779-784.
26. Santomauro A.T., Boden G., Silva M.E., et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999, 48:1836-1841.
27. Reaven G.M., Hollenbeck C., Jeng C.Y., Wu M.S., Chen Y.D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988, 37:1020-1024.
28. Dresner A., Laurent D., Marcucci M., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. JClin Invest 1999, 103:253-259.
29. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
30. Suganami T., Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. JLeukoc Biol 2010, 88:33-39.
31. Cinti S., Mitchell G., Barbatelli G., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. JLipid Res 2005, 46:2347-2355.
32. Stolarczyk E., Vong C.T., Perucha E., et al. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab 2013, 17:520-533.
33. Westcott D.J., Delproposto J.B., Geletka L.M., et al. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. JExp Med 2009, 206:3143-3156.
34. Petersen K.F., Shulman G.I. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 2002, 90:11G-18G.
35. DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32(Suppl.2):S157-S163.
36. Pillon N.J., Bilan P.J., Fink L.N., Klip A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab 2013, 304:E453-E465.
37. Deng T., Lyon C.J., Minze L.J., et al. Class II Major Histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013, 17:411-422.
38. Morris D.L., Cho K.W., Delproposto J.L., et al. Adipose tissue macrophages function as antigen presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013 Aug, 62(8):2762-2772.
39. Zeyda M., Huber J., Prager G., Stulnig T.M. Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity (Silver Spring) 2011, 19:743-748.
40. Surendar J., Mohan V., Rao M.M., Babu S., Aravindhan V. Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103). Diabetes Technol Ther 2011, 13:477-482.
41. Mahrle G., Schulze H.J. Recombinant interferon-gamma (rIFN-gamma) in dermatology. JInvest Dermatol 1990, 95:132S-137S.